Revolution Medicines, Inc. · NASDAQ:RVMD
Anders Jack sold 20,000 Revolution Medicines, Inc. shares (Form 4)
Traded Jun 24, 2026 · Filed Jun 26, 2026
On Jun 24, 2026, Anders Jack (Chief Financial Officer) sold 20,000 Revolution Medicines, Inc. shares at an average US$168.33 for US$3.37M under a trading plan, leaving 123,269 shares. Filed Jun 26, 2026 (Form 4).
- Sold
- 20,000 shares
- Price
- US$168.33 average (US$167.35 to US$170.32)
- Value
- US$3.37M
- Holding after
- 123,269 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 24, 2026 | Common Stock | Option exercise | 20,000 | US$18.56 | 143,269 | Direct |
| Jun 24, 2026 | Common Stock | Sale | 4,553 | US$167.35 | 138,716 | Direct |
| Jun 24, 2026 | Common Stock | Sale | 9,496 | US$168.20 | 129,220 | Direct |
| Jun 24, 2026 | Common Stock | Sale | 5,651 | US$169.24 | 123,569 | Direct |
| Jun 24, 2026 | Common Stock | Sale | 300 | US$170.32 | 123,269 | Direct |
Source
Related
- Revolution Medicines, Inc.
- Anders Jack
- Revolution Medicines, Inc. shareholders
- Form 4 · Anders Jack · Sep 18, 2026
- Form 4 · Anders Jack · Jun 18, 2026
- Form 4 · Sandler Alan B. · Oct 1, 2026
- Form 4 · Cislini Jeff · Sep 29, 2026
- Form 4 · Mancini Anthony · Sep 28, 2026
- Form 4 · Anderson Elizabeth M · Sep 24, 2026
- Form 4 · Mancini Anthony · Sep 22, 2026